| 36254693 | Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial. | Eur Heart J | 2023 |
| 37670404 | Remote heart failure management guided by pulmonary artery pressure home monitoring: rewriting the future? | Eur Heart J | 2023 |
| 37591524 | Real-time pulmonary artery pressure monitoring in heart failure patients: an updated cost-effectiveness analysis. | ESC Heart Fail | 2023 |
| 37678961 | Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry. | JACC Heart Fail | 2023 |
| 35648270 | Prevalence and prognostic impact of chronic kidney disease and anaemia across ACC/AHA precursor and symptomatic heart failure stages. | Clin Res Cardiol | 2023 |
| 37220769 | Remote pulmonary artery pressure monitoring in heart failure care: part of the new normal? | Lancet | 2023 |
| 36974770 | Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF. | Eur J Heart Fail | 2023 |
| 37038330 | The win ratio method in heart failure trials: lessons learnt from EMPULSE. | Eur J Heart Fail | 2023 |
| 36718715 | Longer-Term Effects of Remote Patient Management Following Hospital Discharge After Acute Systolic Heart Failure: The Randomized E-INH Trial. | JACC Heart Fail | 2023 |
| 36196060 | Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF. | Eur J Heart Fail | 2023 |
| 34516969 | A global perspective of racial differences and outcomes in patients presenting with acute heart failure. | Am Heart J | 2022 |
| 35840352 | Effect of adaptive servo ventilation on central sleep apnea and sleep structure in systolic heart failure patients: polysomnography data from the SERVE-HF major sub study. | J Sleep Res | 2022 |
| 35377706 | Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial. | Circulation | 2022 |
| 35429091 | Quality of life assessed 6â¿¿months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure). | Eur J Heart Fail | 2022 |
| 35393622 | Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction. | Eur Heart J | 2022 |
| 35486314 | Digital Technologies to Support Better Outcome and Experience of Care in Patients with Heart Failure. | Curr Heart Fail Rep | 2022 |
| 36066557 | Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trial. | Eur J Heart Fail | 2022 |
| 36054647 | Effects of remote haemodynamic-guided heart failure management in patients with different subtypes of pulmonary hypertension: insights from the MEMS-HF study. | Eur J Heart Fail | 2022 |
| 34913270 | Sex-specific bimodal clustering of left ventricular ejection fraction in patients with acute heart failure. | ESC Heart Fail | 2022 |
| 35246723 | Pulmonary artery sensor system pressure monitoring to improve heart failure outcomes (PASSPORT-HF): rationale and design of the PASSPORT-HF multicenter randomized clinical trial. | Clin Res Cardiol | 2022 |
| 35064730 | Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry. | Eur J Heart Fail | 2022 |
| 35228754 | The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. | Nat Med | 2022 |
| 34738340 | Less loop diuretic use in patients on sacubitril/valsartan undergoing remote pulmonary artery pressure monitoring. | ESC Heart Fail | 2022 |
| 34332057 | Dynamics of Left Ventricular Myocardial Work in Patients Hospitalized for Acute Heart Failure. | J Card Fail | 2021 |
| 33544152 | Heart and brain interactions : Pathophysiology and management of cardio-psycho-neurological disorders. | Herz | 2021 |
| 33647999 | [Care of patients with chronic heart failure: an interdisciplinary challenge]. | Dtsch Med Wochenschr | 2021 |
| 33839078 | Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HF. | JACC Heart Fail | 2021 |
| 33609072 | Sodium-glucose co-transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial. | Eur J Heart Fail | 2021 |
| 33496189 | Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes. | J Am Heart Assoc | 2021 |
| 33934554 | Adaptive anti-myocardial immune response following hospitalization for acute heart failure. | ESC Heart Fail | 2021 |
| 34313541 | A genetic variant alters the secondary structure of the lncRNA H19 and is associated with dilated cardiomyopathy. | RNA Biol | 2021 |
| 30957867 | Efficacy of a web-based intervention for improving psychosocial well-being in patients with implantable cardioverter-defibrillators: the randomized controlled ICD-FORUM trial. | Eur Heart J | 2020 |
| 32087174 | Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. | Lancet Glob Health | 2020 |
| 31784904 | Bioprofiles and mechanistic pathways associated with Cheyne-Stokes respiration: insights from the SERVE-HF trial. | Clin Res Cardiol | 2020 |
| 31951323 | Biomarkers in patients with heart failure and central sleep apnoea: findings from the SERVE-HF trial. | ESC Heart Fail | 2020 |
| 32040032 | Implementing structured heart failure outpatient monitoring and care in real life. | J Cardiovasc Med (Hagerstown) | 2020 |
| 31913404 | Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart Failure. | JAMA Cardiol | 2020 |
| 32003157 | Syncopes and clinical outcome in heart failure: results from prospective clinical study data in Germany. | ESC Heart Fail | 2020 |
| 33074507 | Terminale Herzinsuffizienz: Neue Ansätze der ambulanten Therapie : Kardiologie -- Autoren: G. Güder, C. Angermann, G. Ertl. | MMW Fortschr Med | 2020 |
| 33328035 | Mortality and morbidity 1 year after stopping a remote patient management intervention: extended follow-up results from the telemedical interventional management in patients with heart failure II (TIM-HF2) randomised trial. | Lancet Digit Health | 2020 |
| 32710857 | Correction to: Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. | Lancet Glob Health | 2020 |
| 32592227 | Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF). | Eur J Heart Fail | 2020 |
| 31218793 | Association of serious adverse events with Cheyne-Stokes respiration characteristics in patients with systolic heart failure and central sleep apnoea: A SERVE-Heart Failure substudy analysis. | Respirology | 2020 |
| 30553401 | The omega-3 index in patients with heart failure: A prospective cohort study. | Prostaglandins Leukot Essent Fatty Acids | 2019 |
| 31908619 | The trialist's perspective: what do you need to prove for remote monitoring devices to be approved? | Eur Heart J Suppl | 2019 |
| 31908617 | Implantable devices for heart failure monitoring: the CardioMEMSâ¿¢ system. | Eur Heart J Suppl | 2019 |
| 31658482 | [Hyperkalemia - Pathophysiology, prognostic significance and treatment options]. | Dtsch Med Wochenschr | 2019 |
| 30097684 | Symptom patterns and clinical outcomes in women versus men with systolic heart failure and depression. | Clin Res Cardiol | 2019 |
| 31139330 | Prevalence of cardiovascular risk factors and diseases in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. | Oncotarget | 2019 |
| 30784226 | Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction. | ESC Heart Fail | 2019 |